Trials / Conditions / Malignant Neoplastic Disease
Malignant Neoplastic Disease
5 registered clinical trials studyying Malignant Neoplastic Disease.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Can NCT05840510 | Mirati Therapeutics Inc. | Phase 1 |
| Active Not Recruiting | Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients NCT05375994 | Verastem, Inc. | Phase 1 / Phase 2 |
| Terminated | Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14) NCT04975256 | Mirati Therapeutics Inc. | Phase 1 |
| Completed | Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2) NCT04330664 | Mirati Therapeutics Inc. | Phase 1 |
| Active Not Recruiting | Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1 NCT03785249 | Mirati Therapeutics Inc. | Phase 1 / Phase 2 |